Other
Hemoglobin SC Disease
2
Pipeline Programs↗
0
Active Trials↗
0
Companies Involved↗
Hemoglobin SC Disease is an early-stage landscape with 2 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
Preclinical
No programs
Phase 1
No programs
Phase 3
No programs
Approved
No programs
Analysis
Trial Status
3
clinical trials
Terminated3 · 100%
Clinical Trials
Trial Activity
Treatment of Hemoglobin SC Disease With Hydroxyurea
Terminated·—·Phase 2·NCT02336373·32 enrolled
Oral Magnesium Pidolate, Hemoglobin SC Disease, MG Pidolate
Terminated·—·Phase 2·NCT00040456·12 enrolled
Treatment of Adult Patients With Hemoglobin SC Disease (SCYTHE)
Terminated·—·Phase 2·NCT02640573·1 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)